期刊文献+

急性全髓增殖症伴骨髓纤维化一例并文献复习

原文传递
导出
摘要 目的提高对急性全髓增殖症伴骨髓纤维化(APMF)这一少见疾病的认识。方法对一例APMF患者资料进行回顾分析并复习文献。结果患者为男性,52岁,临床表现为全血细胞减少,外周血和骨髓可见少量幼稚细胞,骨髓“干抽”,骨髓纤维化,脾脏不大,临床过程呈现进展状态,最后表现为急性粒细胞性白血病,患者在1年内死亡。结论APMF是一个独立的疾病,需注意与急性骨髓纤维化、急性白血病伴骨髓纤维化、急性髓系白血病伴多系发育异常等疾病相鉴别。
作者 薛军 谢晓竞
出处 《白血病.淋巴瘤》 CAS 2012年第7期431-433,共3页 Journal of Leukemia & Lymphoma
  • 相关文献

参考文献13

  • 1魏芳,张伟华,张秀莲,葛晓静,闫彩萍.急性全髓增殖症伴骨髓纤维化一例并文献复习[J].白血病.淋巴瘤,2011,20(9):560-562. 被引量:2
  • 2窦立萍,刘源,李绵洋,于力,吴晓雄,李红华,达万明.急性全髓增殖症伴骨髓纤维化1例并文献复习[J].临床血液学杂志,2005,18(3):180-180. 被引量:6
  • 3Lewis SM, Szur L. Malignant myelosclerosis. Br Med J, 1963,2 : 472- 477.
  • 4Weisenburger DD. Acute myelofibrosis terminating as acute myeloblastie leukemia. Am J Clin Pathol, 1980, 73 : 128-132.
  • 5Dunphy CH, Kitchen S, Saravia O, et al. Acute myelofibrosis terminating in acute lymphoblastic leukemia:case report and review of the literature. Am J Hematol, 1996,51 : 85-89.
  • 6Bain BJ, Catovsky D, O'Brien M, et al. Megakaryoblastic leukemia presenting as acute myelofibrosisa study of four cases with the platelet- peroxidase reaction. Blood, 1981,58 : 206-213.
  • 7Brunning RD, Matutes E, Flandrin G, et al. Acute myeloid leukemia not otherwise categorized-acute panmyelosis with myelofibrosis//Jaffe ES, Harris NL, Stein H, et al. World Health Organization Classification of Tumors, Tumors of Haematopoietic and Lymphoid Tissues. Lyon:IARC Press, 2001:103-104.
  • 8Suvajdzic N, Marisavljevic D, Kraguljac N, et al. Acute panmyelosis with myelofibrosis: clinical, immunophenotypic and cytogenetic study of twelve cases. Leuk Lymphoma, 2004,45 : 1873-1879.
  • 9Oraxi A, O'Malley DP, Jiang J, et al. Acute panmyelosis with myelofihr-osis:an entity distinct from acute megakaryoblastic leukemia. Modern Pathol, 2005,18 : 603-614.
  • 10Thiele J, Kvasnicka HM, Zerhusen G, et al. Acute panmyelosis with myelofibrosis:a clinicopathological study on 46 patients including histochemistry of bone marrow biopsies and follow-up. Ann Hematol, 2004,83:513-521.

二级参考文献25

  • 1Kr(o)ger N,Holler E,Kobbe G,et al.Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis:a prospective,multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.Blood,2009,114:5264-5270.
  • 2Zang DY,Deeg HJ.Allogeneic hematopoietic cell transplantation for patients with myelofibrosis.Curr Opin Hematol,2009,16:140-146.
  • 3Thomas DA,Giles FJ,Albitar M,et al.Thalidomide therapy for myelofibrosis with myeloid metaplasia.Cancer,2006,106:1974-1984.
  • 4Abgrall JF,Guibaud I,Bastie JN,et al.Thalidomide versus placebo in myeloid metaplasia with myelofibrosis:a prospective,randomized,double-blind,multicenter study.Haematologica,2006,91:1027-1032.
  • 5Tefferi A,Cortes J,Verstovsek S,et al.Lenalidomide therapy in myelofibrosis with myeloid metaplasia.Blood,2006,108:1158-1164.
  • 6Quint ás-Cardama A,Kantarjian HM,Manshouri T,et al.Lenalidomide plus prednisone results in durable clinical,histopathologic,and molecular responses in patients with myelofibrosis.J Clin Oncol,2009,27:4760-4766.
  • 7Chee L,Kalnins R,Turner P.Low dose melphalan in the treatment of myelofibrosis:a single centre experience.Leuk Lymphoma,2006,47:1409-1412.
  • 8Mishchenko E,Tefferi A.Treatment options for hydroxyurea-refractory disease complications in myeloproliferative neoplasms:JAK2inhibitors,radiotherapy,splenectomy and transjugular intrahepatic portosystemic shunt.Eur J Haematol,2010,Jun 2.[Epub ahead of print].
  • 9Tefferi A,Verstovsek S,Barosi G,et al.Pomalidomide is active in the treatment of anemia associated with myelofibrosis.J Clin Oncol,2009,27:4563-4569.
  • 10Barosi G,Bordessoule D,Briere J,et al.Response criteria for myelofibrosis with myeloid metaplasia:results of an initiative of the European Myelofibrosis Network (EUMNET).Blood,2005,106:2849-2853.

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部